ALEC – alector, inc. (US:NASDAQ)
Stock Stats
News
12/17
08:02 am
alec
Medium
Alector, Inc. (NASDAQ: ALEC) was downgraded by analysts at Mizuho from an "outperform" rating to a "neutral" rating. They now have a $2.50 price target on the stock, down previously from $9.00.
12/16
07:05 am
alec
Medium
Alector, Inc. (NASDAQ: ALEC) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. They now have a $4.00 price target on the stock.
12/4
07:33 am
alec
Medium
Alector, Inc. (NASDAQ: ALEC) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $1.00 price target on the stock, down previously from $9.00.
11/29
08:24 am
alec
Low
Alector, Inc. (NASDAQ: ALEC) had its price target lowered by analysts at HC Wainwright from $35.00 to $7.00. They now have a "buy" rating on the stock.
11/27
11:17 am
alec
Low
ALEC Stock Tanks as Alzheimer's Drug Fails in Mid-Stage Study [Yahoo! Finance]
11/6/2024
04:05 pm
alec
7.6%
BEAT
8/7/2024
04:05 pm
alec
3.9%
BEAT
5/8/2024
04:05 pm
alec
0.2%
BEAT
2/27/2024
04:05 pm
alec
-0.3%
BEAT
12/17
08:02 am
Downgrades
Outperform
Neutral
Mizuho
Medium
-6.0%
12/17
08:02 am
Downgrades
Outperform
Neutral
Mizuho
Medium
-6.0%
12/17
05:02 am
Downgrades
OUTPERFORM
NEUTRAL
MIZUHO
Medium
-4.5%
12/17
05:02 am
Downgrades
OUTPERFORM
NEUTRAL
MIZUHO
Medium
-4.5%
12/16
07:05 am
Downgrades
Buy
Hold
Stifel Nicolaus
Medium
3.7%
12/6
05:31 pm
alec
Medium
Form SC 13G Alector, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
12/3
05:40 pm
alec
High
Form 4 Alector, Inc. For: Dec 02 Filed by: GRASSO MARC
12/3
05:40 pm
alec
High
Form 4 Alector, Inc. For: Dec 02 Filed by: Kenkare-Mitra Sara
12/3
05:40 pm
alec
High
Form 4 Alector, Inc. For: Dec 02 Filed by: Romano Gary
12/3
05:40 pm
alec
High
Form 4 Alector, Inc. For: Dec 02 Filed by: Rosenthal Arnon
Show more
Top News Gainers
2/5 Alector Announces FDA Fast Track Designation Granted to AL101 for the Treatment of Patients with Frontotemporal Dementia 12.0%
1/30 Form EFFECT Alector, Inc. 10.9%
1/8 Alector to Present at the J.P. Morgan 38th Annual Healthcare Conference 10.0%
4/28 Alector Inc (NASDAQ: ALEC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 8.9%
4/17 Form SC 13D/A Alector, Inc. Filed by: ORBIMED ADVISORS LLC 8.0%
2/3 Alector Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 7.1%
5/13 Q1/2019 3/31/2019 EPS -0.420 ZacksConsensus N/A ActVsEst N/A - N/A 6.2%
3/25 Alector Enters into a Licensing Agreement with Innovent Biologics to Develop and Commercialize AL008 in Oncology Indications in China 5.5%
9/9 Alector Initiates Phase 2 Trial of AL001 in Patients with Frontotemporal Dementia 4.7%
12/11 Alector Announces Appointment of Shehnaaz Suliman, M.D., MBA, M.Phil., as President and Chief Operating Officer 4.3%
Top News Decliners
3/30 Form 144 Alector, Inc. Filed by: ORBIMED ADVISORS LLC -22.2%
2/7 Form 4 Alector, Inc. For: Feb 05 Filed by: Paul Robert -19.8%
3/23 Alector Announces the Appointment of Paula Hammond, Ph.D., to the Board of Directors -18.8%
3/17 Alector Inc (NASDAQ: ALEC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $26.00 price target on the stock. -11.1%
2/24 Alector to Present at the Cowen 40th Annual Health Care Conference -11.0%
4/2 Form 4 Alector, Inc. For: Mar 31 Filed by: ORBIMED ADVISORS LLC -8.8%
4/9 Form 144 Alector, Inc. Filed by: ORBIMED ADVISORS LLC -8.0%
12/8 Alector Inc (NASDAQ: ALEC) had its "buy" rating re-affirmed by analysts at Cowen Inc. -6.2%
3/4 Form 4 Alector, Inc. For: Mar 02 Filed by: OrbiMed Capital GP IV LLC -6.0%
1/27 Alector Announces Proposed Public Offering of Common Stock -5.4%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3